IBM Watson Gene officially enters China: Introducing Watson Health Cognitive Intelligence Products
On June 21, 2017, Baiyang Intelligent Technology Co., Ltd. and IBM Watson Health Co., Ltd. jointly launched in Beijing, and Baiyang Intelligent Technology became the exclusive distributor of Watson for Genomics in China. Jointly promote the application of tumor genomic analysis, and provide pathologists and oncologists with recommendations for precise treatment based on oncogenic mutations. This is the second Watson Health cognitive intelligence product introduced after Baiyang Intelligent Technology and IBM reached a strategic cooperation with Watson for Oncology three months ago. This deepening cooperation is expected to promote the application of cognitive intelligence in the medical field. " Accurate medicine " is moving forward. "Precise medical care" is listed in the national strategy, it is difficult to solve the problem In the “13th Five-Year Plan†project announced by the National Development and Reform Commission, “expedited promotion of large-scale application of biotechnology such as genomics†was explicitly included, and “genomics†was included in the national strategy. In fact, as early as March 2015, the Ministry of Science and Technology held the first meeting of China's precision medical strategy experts and proposed the China Precision Medical Plan. A year later, the Ministry of Science and Technology announced the five-year “precise medical research†with a implementation period of 2016-2020. The key special guidelines, China's national strategic deployment of precision medicine is about to begin. The data shows that the state plans to invest 60 billion yuan for China's precision medical plan by 2030. Although precision medicine is the trend of the times, it faces a variety of problems in science, medicine, and clinical development. The two most important difficulties are: First, the genetic testing laboratory lacks standardization. From sampling, to specimen processing to sequencing, this series of processes will lead to inaccurate test results due to non-standardization. China's independent medical laboratory for genetic testing has exceeded 200. At home, quite a few of the tests done by the laboratory have accuracy problems. The second difficulty lies in the interpretation of sequencing results, the use of high-throughput sequencing technology to continuously generate biological information, which needs to be interpreted and researched. The massive scientific medical literature needs to read and extract information, and the quantity is continuously accelerating and updating. The feasibility of manual analysis is further reduced. Watson Health's cognitive computing tools based on big data designed for tumor gene mutations are already the most mature genetic analysis applications. What is Watson for Genomics and how it can help precision medicine At present, cancer gene mutations are found in the field of tumors, and these gene mutations are matched with molecular targeted therapy by searching various data sources, and it takes several days or even several weeks for the patient to interpret the cancer gene report manually. In addition, the increasing number of genetic data and clinical trial data has increased the difficulty of manual analysis of cancer genes, and the cognitive computing tool Watson for Genomics has solved this problem well, with an average of more than 10,000 sciences per month. The paper data and 100 new clinical data can be systematically provided with annotation files for each genomic variation in just a few minutes. Cognitive calculations can accomplish large-scale workloads that cannot be manipulated by conventional humans. Squid Rings Raw,Frozen squid rings,This year's Squid Rings ZHOUSHAN GENHO FOOD CO.,LTD , https://www.genho-food.com
